Curis Inc (CRIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRIS | BMY | AMGN | GILD | REGN |
| Company | Curis Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7600 | 74.31 | 242.99 | 85.40 | 766.34 |
| High | 0.7800 | 74.42 | 243.56 | 86.03 | 768.26 |
| Low | 0.7500 | 72.94 | 239.60 | 85.29 | 748.12 |
| Last | 0.7570 | 73.65 | 240.20 | 85.67 | 749.66 |
| Change | -0.0036 | -0.87 | -3.80 | -0.38 | -20.28 |
| % Change | -0.47% | -1.17% | -1.56% | -0.44% | -2.63% |
| Volume | 238,800 | 10,149,800 | 2,761,200 | 7,376,500 | 617,600 |
| 20-Day Average Volume | 616,315 | 8,597,305 | 2,572,420 | 7,248,630 | 679,350 |
| Previous Close | 0.7606 | 74.52 | 244.00 | 86.05 | 769.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7424 | 72.92 | 256.53 | 84.44 | 740.41 |
| 20-Day Raw Stochastic | 76.46% | 71.56% | 9.47% | 77.23% | 52.04% |
| 20-Day Relative Strength | 55.24% | 50.16% | 26.98% | 53.84% | 52.75% |
| Weighted Alpha | -58.06 | +6.40 | +0.10 | +43.70 | +14.90 |
| Today's Opinion | 8% Sell | 32% Sell | 24% Sell | 56% Buy | 100% Buy |
| Previous Opinion | 8% Sell | 16% Buy | 24% Sell | 72% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 40% Sell | 56% Buy | 88% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.41% since 02/01/23 | +3.40% since 02/01/23 | -2.52% since 02/01/23 | +1.99% since 02/01/23 | -1.10% since 02/01/23 |
| Low | 0.7300 on 02/02/23 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 741.45 on 02/02/23 |
| High | 0.7990 on 02/03/23 | 75.18 on 02/06/23 | 249.96 on 02/03/23 | 87.18 on 02/06/23 | 800.48 on 02/06/23 |
| 1-Month | |||||
| %Chg | +15.61% since 01/06/23 | +0.89% since 01/06/23 | -12.72% since 01/06/23 | -2.74% since 01/06/23 | +1.70% since 01/06/23 |
| Low | 0.6000 on 01/10/23 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 668.00 on 01/09/23 |
| High | 0.7990 on 02/03/23 | 75.18 on 02/06/23 | 276.84 on 01/11/23 | 87.90 on 01/09/23 | 800.48 on 02/06/23 |
| 3-Month | |||||
| %Chg | -2.95% since 11/08/22 | -7.91% since 11/08/22 | -17.85% since 11/08/22 | +4.18% since 11/08/22 | -0.30% since 11/08/22 |
| Low | 0.4700 on 12/27/22 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.07 on 11/11/22 | 668.00 on 01/09/23 |
| High | 0.9296 on 11/15/22 | 81.43 on 12/01/22 | 296.22 on 11/09/22 | 89.74 on 12/13/22 | 800.48 on 02/06/23 |
| 6-Month | |||||
| %Chg | -26.50% since 08/08/22 | -0.20% since 08/08/22 | -2.87% since 08/08/22 | +39.07% since 08/08/22 | +18.87% since 08/08/22 |
| Low | 0.4700 on 12/27/22 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 61.38 on 08/09/22 | 572.22 on 09/06/22 |
| High | 1.7700 on 08/18/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 800.48 on 02/06/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 73,320 | 158,441,424 | 130,193,272 | 107,927,696 | 83,848,008 |
| Shares Outstanding, K | 96,398 | 2,126,160 | 533,579 | 1,254,244 | 108,902 |
| Annual Sales | 10,650,000 | 46,159,000,000 | 26,323,000,000 | 27,281,000,000 | 12,172,900,000 |
| Annual Net Income | -45,440,000 | 6,327,000,000 | 6,552,000,000 | 4,592,000,000 | 4,338,400,000 |
| Last Quarter Sales | 2,830,000 | 11,406,000,000 | 6,839,000,000 | 7,389,000,000 | 3,414,400,000 |
| Last Quarter Net Income | -13,290,000 | 2,022,000,000 | 1,616,000,000 | 1,640,000,000 | 1,197,100,000 |
| 60-Month Beta | 2.89 | 0.43 | 0.63 | 0.39 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 11/09/22 | 1.82 on 02/02/23 | 4.09 on 01/31/23 | 1.67 on 02/02/23 | 12.56 on 02/03/23 |
| Latest Earnings Date | 02/23/23 | 02/02/23 | 01/31/23 | 02/02/23 | 02/03/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 03/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.68 | 13.78 | 11.88 | 18.50 |
